160 related articles for article (PubMed ID: 33544193)
1.
Gassenmaier S; Bares R; Barreuther M; Flaadt T; Lang P; Schaefer JF; Tsiflikas I
Pediatr Radiol; 2021 Jun; 51(7):1223-1230. PubMed ID: 33544193
[TBL] [Abstract][Full Text] [Related]
2. Iodine-123 metaiodobenzylguanidine scintigraphy scoring allows prediction of outcome in patients with stage 4 neuroblastoma: results of the Cologne interscore comparison study.
Decarolis B; Schneider C; Hero B; Simon T; Volland R; Roels F; Dietlein M; Berthold F; Schmidt M
J Clin Oncol; 2013 Mar; 31(7):944-51. PubMed ID: 23341514
[TBL] [Abstract][Full Text] [Related]
3. Comparison between whole-body magnetic resonance imaging and whole-body metaiodobenzylguanidine scintigraphy in the evaluation of primary tumor and metastases in neuroblastoma.
Rodrigues MMC; Lederman HM; Grossman I; Castiglioni MLV; Marchetti R; Grass DC; Luisi FAV; Caran EMM
Pediatr Blood Cancer; 2024 Mar; 71(3):e30820. PubMed ID: 38153317
[TBL] [Abstract][Full Text] [Related]
4. Whole-Body Pediatric Neuroblastoma Imaging: 123I-mIBG and Beyond.
Pai Panandiker AS; Coleman J; Shulkin B
Clin Nucl Med; 2015 Sep; 40(9):737-9. PubMed ID: 26053707
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the utility of
Gauguet JM; Pace-Emerson T; Grant FD; Shusterman S; DuBois SG; Frazier AL; Voss SD
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28449267
[TBL] [Abstract][Full Text] [Related]
6. Whole-body MRI of paediatric malignant tumours: comparison with conventional oncological imaging methods.
Goo HW; Choi SH; Ghim T; Moon HN; Seo JJ
Pediatr Radiol; 2005 Aug; 35(8):766-73. PubMed ID: 15864576
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact and prognostic value of metaiodobenzylguanidine imaging in children with metastatic neuroblastoma.
Perel Y; Conway J; Kletzel M; Goldman J; Weiss S; Feyler A; Cohn SL
J Pediatr Hematol Oncol; 1999; 21(1):13-8. PubMed ID: 10029806
[TBL] [Abstract][Full Text] [Related]
8. Validation of Postinduction Curie Scores in High-Risk Neuroblastoma: A Children's Oncology Group and SIOPEN Group Report on SIOPEN/HR-NBL1.
Yanik GA; Parisi MT; Naranjo A; Nadel H; Gelfand MJ; Park JR; Ladenstein RL; Poetschger U; Boubaker A; Valteau-Couanet D; Lambert B; Castellani MR; Bar-Sever Z; Oudoux A; Kaminska A; Kreissman SG; Shulkin BL; Matthay KK
J Nucl Med; 2018 Mar; 59(3):502-508. PubMed ID: 28887399
[TBL] [Abstract][Full Text] [Related]
9. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
[TBL] [Abstract][Full Text] [Related]
10.
Lewington V; Lambert B; Poetschger U; Sever ZB; Giammarile F; McEwan AJB; Castellani R; Lynch T; Shulkin B; Drobics M; Staudenherz A; Ladenstein R
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):234-241. PubMed ID: 27663238
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of
Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
[TBL] [Abstract][Full Text] [Related]
12. Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma.
Matthay KK; Edeline V; Lumbroso J; Tanguy ML; Asselain B; Zucker JM; Valteau-Couanet D; Hartmann O; Michon J
J Clin Oncol; 2003 Jul; 21(13):2486-91. PubMed ID: 12829667
[TBL] [Abstract][Full Text] [Related]
13. [
Samim A; Blom T; Poot AJ; Windhorst AD; Fiocco M; Tolboom N; Braat AJAT; Viol SLM; van Rooij R; van Noesel MM; Lam MGEH; Tytgat GAM; de Keizer B
Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):1146-1157. PubMed ID: 36504277
[TBL] [Abstract][Full Text] [Related]
14. Comparison of ¹²³I-metaiodobenzylguanidine (MIBG) and ¹³¹I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: a report from the Children's Oncology Group.
Naranjo A; Parisi MT; Shulkin BL; London WB; Matthay KK; Kreissman SG; Yanik GA
Pediatr Blood Cancer; 2011 Jul; 56(7):1041-5. PubMed ID: 21328522
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of iodine-123-labeled metaiodobenzylguanidine single-photon emission computed tomography/computed tomography based on the International Society of Pediatric Oncology Europe Neuroblastoma score in children with neuroblastoma.
Zhou Z; Wang G; Qian L; Liu J; Yang X; Zhang S; Zhang M; Kan Y; Wang W; Yang J
Quant Imaging Med Surg; 2023 Jun; 13(6):3841-3851. PubMed ID: 37284114
[TBL] [Abstract][Full Text] [Related]
16. I-131 mIBG Scintigraphy Curie Versus SIOPEN Scoring: Prognostic Value in Stage 4 Neuroblastoma.
Riaz S; Bashir H; Khan SJ; Qazi A
Mol Imaging Radionucl Ther; 2018 Oct; 27(3):121-125. PubMed ID: 30317848
[TBL] [Abstract][Full Text] [Related]
17. Iodine-131 metaiodobenzylguanidine scintigraphy for localization of lesions in children with neuroblastoma: comparison with computed tomography and ultrasonography.
Lastoria S; Maurea S; Caracò C; Vergara E; Maurelli L; Indolfi P; Casale F; di Tullio MT; Salvatore M
Eur J Nucl Med; 1993 Dec; 20(12):1161-7. PubMed ID: 8299651
[TBL] [Abstract][Full Text] [Related]
18. Added value of SPECT/CT for correlation of MIBG scintigraphy and diagnostic CT in neuroblastoma and pheochromocytoma.
Rozovsky K; Koplewitz BZ; Krausz Y; Revel-Vilk S; Weintraub M; Chisin R; Klein M
AJR Am J Roentgenol; 2008 Apr; 190(4):1085-90. PubMed ID: 18356459
[TBL] [Abstract][Full Text] [Related]
19. The role of 99Tcm-sestamibi scintigraphy in the staging and prediction of the therapeutic response of stage IV neuroblastoma: comparison with 131I-MIBG and 99Tcm-MDP scintigraphy.
Burak Z; Yüksel DA; Cetingül N; Kantar M; Ozkiliç H; Moretti JL
Nucl Med Commun; 1999 Nov; 20(11):991-1000. PubMed ID: 10572908
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma.
Messina JA; Cheng SC; Franc BL; Charron M; Shulkin B; To B; Maris JM; Yanik G; Hawkins RA; Matthay KK
Pediatr Blood Cancer; 2006 Dec; 47(7):865-74. PubMed ID: 16444675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]